Estatísticas para Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration
Total de visitas
views | |
---|---|
Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration | 0 |
Total visitas por mês
views | |
---|---|
junho 2024 | 0 |
julho 2024 | 0 |
agosto 2024 | 0 |
setembro 2024 | 0 |
outubro 2024 | 0 |
novembro 2024 | 0 |
dezembro 2024 | 0 |